Experienced in Hypogonadism Primary Partial Alopecia

Dr. Janice Kerr

Endocrinology
University Of Colorado Hospital
1665 Aurora Ct Fl 2, 
Aurora, CO 
Experienced in Hypogonadism Primary Partial Alopecia
University Of Colorado Hospital
1665 Aurora Ct Fl 2, 
Aurora, CO 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Janice Kerr is an Endocrinologist in Aurora, Colorado. Dr. Kerr is rated as an Experienced provider by MediFind in the treatment of Hypogonadism Primary Partial Alopecia. Her top areas of expertise are Pituitary Tumor, Prolactinoma, Acromegaly, and Anaplastic Thyroid Cancer.

Her clinical research consists of co-authoring 17 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Endocrinology
Licenses
Internal Medicine in CO
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Medica
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO

Locations

University of Colorado Hospital
1665 Aurora Ct Fl 2, Aurora, CO 80045

Additional Areas of Focus

Dr. Kerr has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Hypoparathyroidism

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

An Open-label, Multi-center, Roll-over Study to Assess Long Term Safety in Patients With Endogenous Cushing's Syndrome Who Have Completed a Prior Novartis-sponsored Osilodrostat (LCI699) Study and Are Judged by the Investigator to Benefit From Continued Treatment With Osilodrostat
An Open-label, Multi-center, Roll-over Study to Assess Long Term Safety in Patients With Endogenous Cushing's Syndrome Who Have Completed a Prior Novartis-sponsored Osilodrostat (LCI699) Study and Are Judged by the Investigator to Benefit From Continued Treatment With Osilodrostat
Enrollment Status: Completed
Publish Date: December 18, 2024
Intervention Type: Drug
Study Drug: Osilodrostat
Study Phase: Phase 2
A Phase III, Multi-center, Randomized, Double-blind, 48 Week Study With an Initial 12 Week Placebo-controlled Period to Evaluate the Safety and Efficacy of Osilodrostat in Patients With Cushing's Disease
A Phase III, Multi-center, Randomized, Double-blind, 48 Week Study With an Initial 12 Week Placebo-controlled Period to Evaluate the Safety and Efficacy of Osilodrostat in Patients With Cushing's Disease
Enrollment Status: Completed
Publish Date: November 01, 2021
Intervention Type: Drug
Study Phase: Phase 3
Phase III, Multi-center, Double-blind, Randomized Withdrawal Study of LCI699 Following a 24 Week, Single-arm, Open-label Dose Titration and Treatment Period to Evaluate the Safety and Efficacy of LCI699 for the Treatment of Patients With Cushing's Disease
Phase III, Multi-center, Double-blind, Randomized Withdrawal Study of LCI699 Following a 24 Week, Single-arm, Open-label Dose Titration and Treatment Period to Evaluate the Safety and Efficacy of LCI699 for the Treatment of Patients With Cushing's Disease
Enrollment Status: Completed
Publish Date: January 06, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 2 Less Clinical Trials

17 Total Publications

Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines for the Role of Medical Perioperative Management for Patients With Functioning Pituitary Adenomas.
Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines for the Role of Medical Perioperative Management for Patients With Functioning Pituitary Adenomas.
Journal: Neurosurgery
Published: April 15, 2025
Similar Doctors
Experienced in Hypogonadism Primary Partial Alopecia
Dr. Leslie Gamache
Endocrinology
Experienced in Hypogonadism Primary Partial Alopecia
Dr. Leslie Gamache
Endocrinology

HCA HealthONE Denver Endocrinology

1601 E 19th Ave Ste 5500, 
Denver, CO 
 (6.9 miles away)
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Leslie Gamache is an Endocrinologist in Denver, Colorado. Dr. Gamache is rated as an Advanced provider by MediFind in the treatment of Hypogonadism Primary Partial Alopecia. Her top areas of expertise are Type 1 Diabetes (T1D), Obesity in Children, Hypothyroidism, and Thyroid Nodule.

Experienced in Hypogonadism Primary Partial Alopecia
Dr. Kimberly D. Lerner
Endocrinology
Experienced in Hypogonadism Primary Partial Alopecia
Dr. Kimberly D. Lerner
Endocrinology

Boulder Medical Center

4745 Arapahoe Ave, Ste 200 - Endocrinology, 
Boulder, CO 
 (28.1 miles away)
303-666-2640
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Kimberly Lerner is an Endocrinologist in Boulder, Colorado. Dr. Lerner is rated as a Distinguished provider by MediFind in the treatment of Hypogonadism Primary Partial Alopecia. Her top areas of expertise are Obesity in Children, Hypothyroidism, Postmenopausal Osteoporosis, and Osteoporosis. Dr. Lerner is currently accepting new patients.

Experienced in Hypogonadism Primary Partial Alopecia
Dr. Kelsi Deaver
Endocrinology
Experienced in Hypogonadism Primary Partial Alopecia
Dr. Kelsi Deaver
Endocrinology

Denver Endocrinology Diabetes & Thyroid Center

799 E Hampden Ave Ste 525, 
Englewood, CO 
 (9.4 miles away)
303-321-2466
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Kelsi Deaver is an Endocrinologist in Englewood, Colorado. Dr. Deaver is rated as a Distinguished provider by MediFind in the treatment of Hypogonadism Primary Partial Alopecia. Her top areas of expertise are Obesity in Children, Hypothyroidism, Type 1 Diabetes (T1D), and Thyroid Storm.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kerr's expertise for a condition
ConditionClose
    View All 20 Advanced Conditions
    View All 42 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile